Logo image of OXUR.BR

OXURION NV (OXUR.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:OXUR - BE0974487192 - Common Stock

0.0072 EUR
0 (-2.7%)
Last: 12/31/2025, 7:00:00 PM
Fundamental Rating

2

Overall OXUR gets a fundamental rating of 2 out of 10. We evaluated OXUR against 81 industry peers in the Biotechnology industry. Both the profitability and financial health of OXUR have multiple concerns. OXUR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year OXUR was profitable.
In the past year OXUR has reported a negative cash flow from operations.
In the past 5 years OXUR reported 4 times negative net income.
OXUR had a negative operating cash flow in each of the past 5 years.
OXUR.BR Yearly Net Income VS EBIT VS OCF VS FCFOXUR.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

With an excellent Return On Assets value of 39.34%, OXUR belongs to the best of the industry, outperforming 98.77% of the companies in the same industry.
Industry RankSector Rank
ROA 39.34%
ROE N/A
ROIC N/A
ROA(3y)-183.9%
ROA(5y)-157.58%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OXUR.BR Yearly ROA, ROE, ROICOXUR.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K

1.3 Margins

OXUR has a Profit Margin of 97950.00%. This is amongst the best in the industry. OXUR outperforms 100.00% of its industry peers.
The Operating Margin of OXUR (45050.00%) is better than 100.00% of its industry peers.
Industry RankSector Rank
OM 45050%
PM (TTM) 97950%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OXUR.BR Yearly Profit, Operating, Gross MarginsOXUR.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K -5K 10K

More info and screens

0

2. Health

2.1 Basic Checks

OXUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OXUR has more shares outstanding
Compared to 5 years ago, OXUR has more shares outstanding
The debt/assets ratio for OXUR is higher compared to a year ago.
OXUR.BR Yearly Shares OutstandingOXUR.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
OXUR.BR Yearly Total Debt VS Total AssetsOXUR.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

OXUR has an Altman-Z score of -27.36. This is a bad value and indicates that OXUR is not financially healthy and even has some risk of bankruptcy.
OXUR has a worse Altman-Z score (-27.36) than 83.95% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -27.36
ROIC/WACCN/A
WACC1.79%
OXUR.BR Yearly LT Debt VS Equity VS FCFOXUR.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

OXUR has a Current Ratio of 0.17. This is a bad value and indicates that OXUR is not financially healthy enough and could expect problems in meeting its short term obligations.
OXUR has a Current ratio of 0.17. This is amonst the worse of the industry: OXUR underperforms 95.06% of its industry peers.
A Quick Ratio of 0.17 indicates that OXUR may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.17, OXUR is doing worse than 95.06% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.17
OXUR.BR Yearly Current Assets VS Current LiabilitesOXUR.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 101.88% over the past year.
OXUR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -97.62%.
OXUR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -76.22% yearly.
EPS 1Y (TTM)101.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.92%
Revenue 1Y (TTM)-97.62%
Revenue growth 3Y-86.15%
Revenue growth 5Y-76.22%
Sales Q2Q%-100%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OXUR.BR Yearly Revenue VS EstimatesOXUR.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
OXUR.BR Yearly EPS VS EstimatesOXUR.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 -2K -4K -6K -8K -10K

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.01 indicates a rather cheap valuation of OXUR.
Based on the Price/Earnings ratio, OXUR is valued cheaper than 100.00% of the companies in the same industry.
OXUR is valuated cheaply when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.01
Fwd PE N/A
OXUR.BR Price Earnings VS Forward Price EarningsOXUR.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

OXUR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. OXUR is cheaper than 83.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.65
OXUR.BR Per share dataOXUR.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OXUR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

OXURION NV

EBR:OXUR (12/31/2025, 7:00:00 PM)

0.0072

0 (-2.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)09-30 2025-09-30
Earnings (Next)04-03 2026-04-03/amc
Inst Owners0.22%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap450.72K
Revenue(TTM)2.00K
Net Income(TTM)1.96M
Analysts42.22
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.01
Fwd PE N/A
P/S 225.36
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 11.65
EPS(TTM)0.61
EY8472.22%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS-0.19
TBVpS-0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 39.34%
ROE N/A
ROCE -7.59%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 45050%
PM (TTM) 97950%
GM N/A
FCFM N/A
ROA(3y)-183.9%
ROA(5y)-157.58%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 4.92
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.17
Altman-Z -27.36
F-Score4
WACC1.79%
ROIC/WACCN/A
Cap/Depr(3y)1.58%
Cap/Depr(5y)3.23%
Cap/Sales(3y)3.43%
Cap/Sales(5y)3.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.92%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-97.62%
Revenue growth 3Y-86.15%
Revenue growth 5Y-76.22%
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y112.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y87.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y87.87%
OCF growth 3YN/A
OCF growth 5YN/A

OXURION NV / OXUR.BR FAQ

What is the ChartMill fundamental rating of OXURION NV (OXUR.BR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to OXUR.BR.


What is the valuation status for OXUR stock?

ChartMill assigns a valuation rating of 3 / 10 to OXURION NV (OXUR.BR). This can be considered as Overvalued.


Can you provide the profitability details for OXURION NV?

OXURION NV (OXUR.BR) has a profitability rating of 3 / 10.


Can you provide the financial health for OXUR stock?

The financial health rating of OXURION NV (OXUR.BR) is 0 / 10.